Non-Hodgkin's Lymphoma
Immunotherapy with Epratuzumab Demonstrates Clinical Efficacy
Published in Vaccine Weekly, September 20th, 2000
"CD22 is a B-cell specific antigen which is commonly expressed in indolent and aggressive NHL," stated John P. Leonard and colleagues from Weill Medical College of Cornell University and New York Presbyterian Hospital, and Immunomedics, Inc., and Garden State Cancer Center, New Jersey.
"Epratuzumab (Hll2 or LymphoCide), Immunomedics, Inc., Morris Plains, New Jersey) binds CD22, and in radiolabeled forms has been demonstrated to have...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2000-09-20)
More Articles from Vaccine Weekly
- Cancer Vaccines
Mycobacterium tuberculosis Ag38 Gene Cooperates with Interleukin 12 Against Tumors - Bacillus Calmette-Guerin Vaccine
Discontinuation Did Not Increase Risk of TB and Meningitis in China - HIV Vaccines
SIV gag DNA-Vaccinated Monkeys Develop Protective Immune Responses - Influenza
DNA-Based Flu Vaccine Raises Protective Immunity; Could be Model for Other Antiviral Vaccines - Pneumococcal Disease
Cellular 'Vehicle' that Transports Pneumonia Discovered - Prostate Cancer
Phase I Trial Targets Monoclonal Antibody to Prostate-Specific Membrane Antigen - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
